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ABSTRACT Cellsurfaceexpressionofsialicacidhasbeenreportedtodecreaseduringimmunecellactivation,butthesigniﬁcance
and regulation of this phenomenon are still being investigated. The major human bacterial pathogen Streptococcus pneumoniae
causes pneumonia, sepsis and meningitis, often accompanied by strong inﬂammatory responses. S. pneumoniae expresses a
sialidase(NanA)thatcontributestomucosalcolonization,plateletclearance,andblood-brainbarrierpenetration.Usingwild-
type and isogenic NanA-deﬁcient mutant strains, we showed that S. pneumoniae NanA can desialylate the surface of human
THP-1monocytes,leadingtoincreasedERKphosphorylation,NF-Bactivation,andproinﬂammatorycytokinerelease. S.
pneumoniaeNanAexpressionalsostimulatesinterleukin-8releaseandextracellulartrapformationfromhumanneutrophils.A
mechanisticcontributionofunmaskingofinhibitorySiglec-5from cissialicacidinteractionstotheproinﬂammatoryeffectof
NanAissuggestedbydecreasedSHP-2recruitmenttotheSiglec-5intracellulardomainandRNAinterferencestudies.Finally,
NanA increased production of proinﬂammatory cytokines in a murine intranasal challenge model of S. pneumoniae pneumonia.
IMPORTANCE Sialicacidsdecoratethesurfaceofallmammaliancellsandplayimportantrolesinphysiology,development,and
evolution.Siglecsaresialicacid-bindingreceptorsonthesurfaceofimmunecells,manyofwhichengagein cisinteractionswith
hostsialoglycanligandsanddampeninﬂammatoryresponsesthroughtransductionofinhibitorysignals.Recently,certainbac-
terialpathogenshavebeenshowntosuppressleukocyteinnateimmuneresponsesbymolecularmimicryofhostsialicacidstruc-
turesandengagementofinhibitorySiglecs.Ourpresentworkshowsthattheconversecanbetrue,i.e.,thatamicrobialsialic
acid-cleavingenzymecaninduceproinﬂammatoryresponses,whichareinpartmediatedbyunmaskingofaninhibitorySiglec.
Weconcludethathostleukocytesarepoisedtodetectandrespondtomicrobialsialidaseactivitywithexaggeratedinﬂammatory
responses,whichcouldbebeneﬁcialordetrimentaltothehostdependingonthesite,stageandmagnitudeofinfection.
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S
ialic acids are nine-carbon sugars prominently displayed as
terminal monosaccharides on surface expressed glycoconju-
gates of all mammalian cells (1, 2). Sialic acids serve key roles in a
diverse array of physiological and pathological processes, includ-
ing organ development, immune regulation, microbial binding,
malignancy,andaspectsofhumanevolution(1,2).Animportant
facet of sialic acid biology is the function of immunoreceptors
called sialic acid-binding immunoglobulin-like lectins, or Siglecs,
which are differentially expressed across the major leukocyte lin-
eages (3–5). A subset of these are the CD33-related Siglecs
(CD33rSiglecs), whose extracellular sialic binding domains are
typically paired with a cytoplasmic domain containing both a
membrane-proximal immunoreceptor tyrosine-based inhibitory
motif (ITIM) and a membrane-distal ITIM-like motif (3, 5).
Two inhibitory CD33rSiglecs expressed prominently on
monocytes/macrophages and neutrophils are Siglec-5 and
Siglec-9, which recruit phosphatases SHP-1 and SHP-2 to their
ITIM and ITIM-like cytoplasmic domains, thereby antagonizing
kinase-dependent activation cascades (6). Since the local concen-
tration of sialic acids on surfaces of leukocytes is very high, per-
haps exceeding 100 mM (7), Siglec binding sites are typically
“masked” by cis interactions with other sialoglycan ligands ex-
pressed on the same cell and can be unmasked by sialidase treat-
ment (8). The widespread expression of host sialic acids and the
prominenceofcognateITIM-bearingCD33rSiglecsoninnateim-
munecellssuggestthattheymayfunctionin“self-recognition”as
“self-associated molecular patterns,” dampening innate immune
responses to prevent autoreactivity (3, 5, 9).
A number of bacteria synthesize sialic acids or acquire them
fromthehostenvironmentandincorporatethemintocellwallor
surfacecomponentssuchaslipooligosaccharides(LOS),lipopoly-
saccharides (LPS), or capsular polysaccharides (CPS) (10). In
some cases, “molecular mimicry” of host sialic acid epitopes al-
lows the pathogen to engage inhibitory Siglecs, contributing to
virulence by suppressing immune responses or altering leukocyte
differentiation programs. For example, the sialylated CPS of
group B streptococcus can engage Siglec-9 to suppress neutrophil
activation (11–13) and the sialylated LOS of Campylobacter jejuni
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sponses to Th1 or Th2 polarization (14, 15).
In contrast, numerous microbial pathogens express enzymes
that cleave sialic acid (sialidases; also called neuraminidases) (16,
17),suchasthevirusescausinginﬂuenza(18)ormumps(19),the
bacterialpathogensStreptococcuspneumoniae(20)andPseudomo-
nasaeruginosa(21),thefungusAspergillusfumigatus(22),andthe
protozoan parasite Trypanosoma cruzi (23). The overall extent of
cell surface sialylation has been found to decrease in activated
macrophages, neutrophils, B cells, T cells, and natural killer cells
(24–28),suggestingthat“unmasking”ofSiglecsfromcissialicacid
engagementoccursduringimmuneactivation(27).Theprocesses
thatdynamicallyregulateSiglecunmaskingareunknownbutmay
inpartinvolveendogenousmammaliansialidases(8),suchasthat
encodedbytheneu-1genelocatedwithinthemajorhistocompat-
ibility complex in humans (26, 29). A potential role of sialidases
produced by microbial pathogens in Siglec unmasking has not
been studied.
We hypothesized that if bacterial sialic acid mimicry could
suppress host innate immune cell responses via engagement of
inhibitory Siglecs, then cell surface desialylation by a bacterial
sialidase could have contrasting effects. S. pneumoniae is the lead-
ing human bacterial pathogen causing upper respiratory tract in-
fections, pneumonia, sepsis and meningitis, resulting in over a
million deaths worldwide each year (30). To establish an experi-
mental model for testing our hypothesis, we used isogenic strains
of S. pneumoniae expressing or lacking their major sialidase, the
surface-anchored NanA. The effect of S. pneumoniae sialidase ex-
pressiononproinﬂammatorycytokineresponseswasexaminedin
a human monocyte cell line and in primary neutrophils and then
extended to a murine model of pneumococcal pneumonia. We
document a proinﬂammatory effect of S. pneumoniae desialyla-
tion of the leukocyte cell surface associated with ERK phosphory-
lationandNF-Bactivation.Evidenceisprovidedthatunmasking
of Siglec-5, the inhibitory CD33rSiglec, is a contributing factor to
this phenomenon.
RESULTS
S.pneumoniaesialidase(NanA)mediatescellsurfacedesialyla-
tion and increases monocyte cytokine responses. NanA from S.
pneumoniae has been shown to desialylate human airway epithe-
lial cell glycoconjugates in vitro (31). We tested whether infection
ofhumanmonocyticcellswithwild-type(WT)S.pneumoniaeled
to general cell surface desialylation. As shown in Fig. 1A, S.
pneumoniae-infected THP-1 cells exhibited a clear dose-
dependent increase in Erythrina cristagalli agglutinin lectin bind-
ing, indicating removal of terminal sialic acids and exposure of
underlying Gal1-4GlcNAc1 units. The isogenic sialidase-
deﬁcient S. pneumoniae mutant (NanA) did not demonstrate
suchactivityatthesamemultiplicityofinfection(MOI),conﬁrm-
ing that the increased E. cristagalli agglutinin binding was due to
sialidase action. THP-1 cells were then challenged with WT or
NanA S. pneumoniae for different time intervals, and the release
of proinﬂammatory cytokines into the culture supernatant was
determined by enzyme-linked immunosorbent assay (ELISA). A
signiﬁcant increase in secretion of tumor necrosis factor alpha
(TNF-), interleukin-6 (IL-6), and IL-8 from S. pneumoniae-
infectedTHP-1monocytescomparedtoNanAmutant-infected
monocytes was observed 2 h postinfection (Fig. 1B). Similar ﬁnd-
ings were observed for TNF- production with the U937 human
monocytic cell line (data not shown). Augmented cytokine re-
sponses were not a byproduct of differing growth or survival of
WT S. pneumoniae versus NanA S. pneumoniae, because THP-1
displayed no obvious bactericidal activity and no differences in
THP-1 phagocytosis between the S. pneumoniae and NanA mu-
tant strains were found (data not shown). Complementation of
the S. pneumoniae NanA mutant with the NanA enzyme ex-
pressed on a plasmid vector partially restored the cytokine stimu-
lation phenotype; in contrast, complementation of the NanA
mutant with an enzymatically inactive version of NanA (32) had
noeffect(Fig.1C).TheseobservationsindicatethatS.pneumoniae
NanA is required for monocyte cell surface desialylation and that
the enzymatic activity is associated with elevated proinﬂamma-
tory cytokine responses. Addition of recombinant puriﬁed Ar-
throbacter ureafaciens sialidase did not itself augment THP-1
monocyte production of TNF-; neither did it restore the TNF-
inducedbytheNanAmutanttothelevelsinducedbytheWTor
pNanA-complemented mutant strains (Fig. 1D). Also, puriﬁed
recombinantS.pneumoniaeNanAenzyme(fromQA-Bio)didnot
induce increased release of TNF- from unstimulated or lipo-
teichoicacid(LTA)-stimulatedTHP-1monocytes(Fig.1E).Thus,
the action of NanA desialylation to lower the activation threshold
ofTHP-1cellsoccursonlyinthecontextoftheliveS.pneumoniae
infection and is perhaps mediated by desialylation events trig-
geredbysurface-anchoredNanAatthesiteofbacterium-hostcell
engagement.
S.pneumoniaeNanA-stimulatedmonocytesupernatantsin-
creasehBMECpermeability.Duringsepsisandmeningitis,over-
activationofinﬂammatorymonocytes/macrophagesisfelttoplay
an important role in endothelial barrier dysfunction (33), and
increasedblood-brainbarrierpermeabilityandmeningealTNF-
levels are found in S. pneumoniae-challenged mice (34). We ob-
servedthatsupernatantsfromWTS.pneumoniae-infectedTHP-1
cells signiﬁcantly increased the permeability of human brain mi-
crovascularendothelialcell(hBMEC)monolayersbyalargeindi-
cator protein (horseradish peroxidase [HRP]) compared to the
supernatants collected from uninfected or NanA mutant-
infected THP-1 cells (Fig. 1F). Neither puriﬁed supernatant from
WTS.pneumoniaebacteria(grownintheabsenceofTHP-1cells)
nor recombinant NanA itself was sufﬁcient to induce hBMEC
permeability (Fig. 1G). These ﬁnding suggests that NanA-
mediated surface desialylation can increase monocyte release of
proinﬂammatorycytokines,withpotentialdownstreameffectson
endothelial cell permeability.
S. pneumoniae sialidase NanA increases neutrophil IL-8 se-
cretion and neutrophil extracellular trap (NET) formation.
Neutrophils are critical ﬁrst-line effector immune cells in the in-
natehostresponsetobacterialinfection.AsshowninFig.2A,WT
S.pneumoniaeinducedsigniﬁcantlymoreIL-8secretionfromhu-
man neutrophils than did the isogenic NanA mutant. Neutro-
philextracellulartraps(NETs)arenetworksofextracellularﬁbers
composed of DNA, histones, and embedded antimicrobial pep-
tides and enzymes capable of capturing and killing bacterial
pathogens (35, 36). Using a myeloperoxidase stain to aid in visu-
alization and quantiﬁcation of NETs, we found that WT S. pneu-
moniae induced more NET formation than the NanA mutant
(Fig. 2B and C). Thus, S. pneumoniae sialidase production en-
hancesinnateimmuneactivationofneutrophilsinafashionanal-
ogous to our observations in THP-1 monocytes.
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activation by S. pneumoniae NanA. Bacterial infections are well
known to activate pattern recognition pathways such as Toll-like
receptors (TLRs) to initiate downstream signaling leading to
mitogen-activatedproteinkinase(MAPK)andNF-Bactivation.
We ﬁrst analyzed the activation of ERK, Jun N-terminal protein
kinase (JNK), and p38 MAPKs by Western blotting using speciﬁc
antibodies (Abs) recognizing the activated phosphorylated forms
of each protein. We found that, while THP-1 cells infected with
WTS.pneumoniaeexhibitedgreaterphosphorylationofERKthan
those infected with the NanA mutant (Fig. 3A), there was no
detectable phosphorylation for p38 and JNK when subjected to
FIG 1 S. pneumoniae sialidase (NanA) mediates cell surface desialylation and increases monocyte cytokine responses. Surface desialylation was determined by
FITC-conjugated E. cristagalli agglutinin staining of human THP-1 monocytes infected with WT S. pneumoniae or NanA mutant for 3 h. Green line, MOI 
10;pinkline,MOI3;blueline,MOI1.(B)Timecourseanalysisofproinﬂammatorycytokineproduction.THP-1cellswereinfectedwithWTS.pneumoniae
or NanA mutant at an MOI  10 for 30 min or 1, 2, or 4 h, and the amount of IL-6, IL-8, and TNF- produced in the culture supernatant was measured by
ELISA. Experiments were conducted three times with biological duplicates. (C) TNF- concentration in supernatants collected 3 h postinfection from THP-1
cells challenged with WT S. pneumoniae, NanA mutant, or the NanA mutant strain complemented with NanA or enzymatically inactive NanA expression
plasmids. Experiments were performed twice with biological duplicates. (D) Addition of recombinant Arthrobacter ureadaciens sialidase (rAUS, 50 mU/ml)
from Arthrobacter ureadaciens did not undo the reduction in the level of TNF- stimulation observed with the NanA mutant. (E) Puriﬁed recombinant NanA
alone did not induce TNF- release from unstimulated or lipoteichoic acid (LTA)-stimulated THP-1 monocytes. SPN, S. pneumoniae. (F) Permeabilization of
hBMEC monolayers. Culture supernatants of THP-1 cells were collected 4 h after infection with WT S. pneumoniae or the NanA mutant strain or mock
infection, and then the permeability of hBMECs was assessed by measuring HRP passage following an 8-h incubation of hBMECs with the collected THP-1
supernatants. Experiments were done twice with biological triplicates. H.I., heat inactivated. (G) Neither WT S. pneumoniae bacterial culture supernatant nor
puriﬁed recombinant NanA is sufﬁcient to induce hBMEC permeability, indicating that NanA-mediated cytokine induction from THP-1 cells is the major
inducing factor. VEGF  vascular endothelial growth factor, used at 200 ng/ml as a positive control. Statistical analysis was performed using Student’s t test (B)
or one-way analysis of variance (ANOVA) with Tukey’s posttest (C and F). ***, P  0.001; **, P  0.01; *, P  0.05.
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monocyteswithWTS.pneumoniaeledtoaccelerateddegradation
of IB compared to infection with the NanA mutant, indicating
liberation of NF-B for nuclear translocation and inﬂammatory
cytokine gene transcription (Fig. 3A). Increased ERK phosphory-
lation and IB degradation in response to S. pneumoniae sialidase
activity are in accordance with the enhanced secretion of inﬂam-
matory cytokines in the S. pneumoniae-infected THP-1 cells
(Fig. 1B and 1C) and with earlier published ﬁndings in which
exogenous addition of a sialidase enzyme enhanced reactivity of
phytohemagglutinin-treatedlymphocytes(37)orERKphosphor-
ylation and cytokine production in LPS-treated monocytes (38).
CD33rSiglecs have been shown to downregulate both innate
and acquired immune responses, likely via cytoplasmic immuno-
receptor tyrosine-based inhibitory motifs (ITIMs) that recruit
SHP family proteases to suppress tyrosine kinase-dependent sig-
nals (3, 39). Siglec-5 and Siglec-9 are the predominant
CD33rSiglecs expressed on monocytes and neutrophils. Since
THP-1 cells have been shown to express Siglec-5 but possess no
detectable mRNA for Siglec-9 (40), we immunoprecipitated
Siglec-5 to analyze SHP-2 recruitment status following WT S.
pneumoniae or NanA mutant infection. As shown in Fig. 3A,
surface desialylation by WT S. pneumoniae infection reduced
SHP-2 recruitment to Siglec-5 compared to results obtained with
NanA mutant-infected monocytes. Temporally, diminished
SHP-2 recruitment occurred earlier (30 min to 1 h postinfection)
than ERK activation (1 to 2 h postinfection). This observation
suggested that decreased inhibitory signals transduced from Si-
glec-5/SHP after surface desialylation to uncap Siglec receptors
interactioncouldaffecttheactivationstatusoftheinfectedmono-
cytes.WeusedRNAinterferencetosilencethecellsurfaceexpres-
sion of Siglec-5 on THP-1 cells and conﬁrmed knockdown efﬁ-
ciency by ﬂuorescence-activated cell sorter (FACS) analysis. As
shown in Fig. 3B, THP-1 cells infected with Siglec-5 short hairpin
RNA(shRNA)lentivirusshowedverylittleornoSiglec-5staining
comparedtoparentalTHP-1cellsandTHP-1cellsinfectedwitha
controllentivirus.SupernatantsfromcontrolandSiglec-5knock-
down THP-1 cells were then collected after infection with WT S.
pneumoniaeorNanAmutantforTNF-quantitation.Asseenin
parental THP-1 cells (Fig. 1B), S. pneumoniae infection induced
moreTNF-secretionincontrollentivirus-infectedcellsthandid
infection with the NanA mutant (Fig. 3C). Although WT S.
pneumoniaestilltriggeredmoreTNF-secretionthantheNanA
mutant in Siglec-5 knockdown cells, the difference was not as
pronouncedasthatobservedincontrolcells.Further,theamount
of TNF- secretion in response to NanA mutant infection was
increased in the Siglec-5 knockdown THP-1 cells (Fig. 3C). Our
ﬁndings suggested that NanA-mediated disruption of the Siglec-
FIG 2 S. pneumoniae sialidase NanA increases neutrophil IL-8 secretion and extracellular trap (NET) formation. (A) Neutrophils were infected with WT S.
pneumoniae or NanA mutant (MOI  10) for 1 or 2 h, and IL-8 released into the culture supernatant was measured by ELISA. Experiments were done twice
with biological duplicates from two different donors. (B) Quantiﬁcation of NETs after coincubation of neutrophils with WT S. pneumoniae or NanA mutant
at an MOI  0.1 for 90 min. Cells were ﬁxed and stained with primary rabbit anti-myeloperoxidase (anti-MPO) antibody followed by a secondary Alexa
488-conjugated goat anti-rabbit antibody to visualize NETs (green). DNA is stained with DAPI (blue). Representative immunoﬂuorescence micrographs of
NETs are shown in panel C, and quantitative results are shown in panel B. Statistics analysis was performed using Student’s t test. **, P  0.01.
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mediatedinhibitorysignalsandcontributetothephenomenonof
increased macrophage proinﬂammatory cytokine release.
S. pneumoniae NanA expression increases production of
multiple inﬂammatory cytokines in a mouse intranasal infec-
tion model. Previous work in a chinchilla otitis model showed
that infection with WT S. pneumoniae but not a NanA-deﬁcient
mutantstronglydecreasedSambucusnigraagglutininlabeling,in-
dicating loss of cell surface sialic acid residues and resulting in
exposure of underlying galactose residues (41). We examined
whether infectious challenge with WT S. pneumoniae versus the
NanA mutant would alter proinﬂammatory cytokine responses
in vivo using a murine intranasal challenge model of pneumonia.
Signiﬁcantly higher levels of TNF- (6 h postchallenge) and IL-6
(20 h postchallenge) were present in the bronchoalveolar lavage
(BAL) ﬂuid of WT S. pneumoniae-infected animals compared to
BAL ﬂuid recovered from NanA mutant-infected mice (Fig. 4A
and B). At the 20 h postinfection time point, signiﬁcantly in-
creasedlevelsofIL-6andIL-1wereidentiﬁedinhomogenatesof
lung tissue (Fig. 4C and D). The differences in cytokine produc-
tion in BAL ﬂuid and lungs were not due to different numbers of
macrophages and neutrophils, because similar cell counts (P 
0.1649) were obtained with the BAL ﬂuid recovered from WT S.
pneumoniaeandNanAmutant-infectedanimals(Fig.4E).Inter-
estingly, fewer WT S. pneumoniae bacteria than NanA mutant
bacteriawererecoveredfromBALﬂuids(Fig.4F),suggestingthat
a greater inﬂammatory response or NET induction elicited by
NanA sialidase activity increased bacterial clearance during the
short-term-infection period.
DISCUSSION
In the present report, we demonstrate that S. pneumoniae NanA
augments proinﬂammatory cytokine production by human
THP-1 cells and neutrophils during S. pneumoniae infection in
vitro. This novel function of NanA-mediated desialylation may
derive from unmasking of an inhibitory CD33rSiglec(s) from cis
ligandsandwascorroboratedbyacceleratedIBdegradation,en-
hancedERKphosphorylation,andreducedSHP-2recruitmentto
Siglec-5.
The mammalian host protects itself from infection through
rapid recognition of pathogens and activation of innate immune
responses; however, unregulated activation can produce detri-
mental consequences of systemic inﬂammation, multiorgan fail-
ure, and disseminated intravascular coagulation (DIC) (42, 43).
FIG 3 Signaling pathways implicated in macrophage inﬂammatory activation by S. pneumoniae NanA. (A) THP-1 cells were infected with WT S. pneumoniae
or NanA mutant at an MOI  10. At the indicated times, cell lysates were analyzed by immunoblotting for ERK1/2 phosphorylation and IB degradation.
SHP-2recruitmenttoSiglec-5wasrevealedbyimmunoprecipitatingcelllyateswithanti-Siglec-5Ab,followedbyprobingwithanti-SHP-2Ab.(B)Knockdown
of Siglec-5 expression by RNA interference. THP-1 cells were infected with lentiviruses carrying control shRNA (thin line) or Siglec-5 targeting shRNA (dashed
line), and the knockdown efﬁciency was determined by FACS analysis with APC-conjugated anti-Siglec-5 MAb to measure cell surface Siglec-5 expression.
THP-1cellsstainedwithAPC-conjugatedisotypeMAb(solidgray)andanti-Siglec-5MAb(thickline)servedasnegativeandpositivecontrols,respectively.(C)
Control or Siglec-5 knockdown THP-1 cells were infected with WT S. pneumoniae or NanA mutant at MOI  10 for 3 h, and the culture supernatants were
collected to determine TNF- concentrations. Experiments were conducted twice with biological duplicates. Statistical analysis was performed by one-way
ANOVA with Tukey’s posttest. ***, P  0.001; **, P  0.01; *, P  0.05.
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trolled, and it is widely accepted that receptors containing immu-
noreceptor tyrosine-based inhibitory motifs (ITIMs) can be em-
ployed to switch off cellular responses through recruitment of
phosphotyrosine phosphatases (PTPs) such as SHP-1 and SHP-2
to decrease tyrosine phosphorylation. Moreover, the engagement
of inhibitory ITIM-containing receptors also blocks activation
signals originating from receptors associated with immunorecep-
tor tyrosine-based activating motifs (ITAMs) (44, 45). Given the
ubiquitous expression of sialic acids on mammalian cell surfaces
and the prominence of cognate ITIM-bearing CD33rSiglecs on
immune cells, Siglecs are speculated to control the activation
threshold of immune cells (3, 5), using sialic acids as “self-
associated molecular patterns” (9). Our ﬁndings provide new ev-
idence to support the hypothesis that unmasking Siglecs from cis
ligands can increase immune cell inﬂammatory responses.
We observed more SHP-2 recruitment to Siglec-5 in THP-1
monocytes after infection with the NanA mutant compared to
thoseinfectedwiththeWTS.pneumoniaeparentstrain.Thisﬁnd-
ing suggests that reduced Siglec-mediated inhibitory signals are
involvedintheNanA-dependentproinﬂammatorycytokinestim-
ulation phenotype. In addition, knockdown of the expression of
Siglec-5intheTHP-1cellsreduceddifferentialcytokineinduction
elicited by WT S. pneumoniae versus the NanA mutant. This
ﬁnding further supported the hypothesis that unmasking of
Siglec-5 by NanA is critical to enhance proinﬂammatory cytokine
production during S. pneumoniae infection. THP-1 cells have no
detectable mRNA of Siglec-9 (40); however, knockdown of the
Siglec-5 expression still did not completely abolish the NanA-
dependent proinﬂammatory cytokine induction increases. Al-
though the NanA mutant in S. pneumoniae strain D39 has negli-
gibleresidualactivity,asshownbyinvitrosialidaseassays(32,46),
an indispensable secondary role of S. pneumoniae sialidases such
as NanB cannot be summarily excluded (47). In addition, mam-
malianNeu1sialidasewasshowntoformacomplexwithToll-like
receptor-2 (TLR2), TLR3, and TLR4 and facilitate TLR4 cluster-
ing, MyD88/TLR4 complex formation, and subsequent NF-B
activation upon LPS engagement (48, 49). Indeed, puriﬁed S.
pneumoniae NanA and Trypanosoma cruzi trans-sialidase were
demonstratedtoactivateNF-Bsignalingpathwaysintheabsence
of TLR ligands (48). Therefore, it is possible that, in addition to
inhibitory Siglec unmasking, TLR2/TLR6, a receptor complex for
Gram-positive bacterial recognition, could also be desialylated by
endogenous Neu1 or by NanA itself upon S. pneumoniae infec-
tion, facilitating its dimerization and downstream signaling acti-
vation.
NanA-mediated desialylation affects numerous glycoconju-
gates(glycoproteinsandglycolipids)onthehostcellsurface,since
their structures are often capped by terminal sialic acids. Further-
more, such desialylation can simultaneously expose underlying
N-acetyllactosamine (Gal1-4GlcNAc) ligands for galectins. Ga-
lectins can bind and translate this glycan-encoded information
intoimmunecellactivation,differentiation,andhomeostaticpro-
grams. These lectins appear to function by forming ordered ga-
lectin–glycan lattices on the cell surface, leading to immunoregu-
latory activities (50, 51). For example, galectin-3-mediated ligand
FIG 4 S. pneumoniae NanA expression increases production of multiple inﬂammatory cytokines in a mouse intranasal infection model. Mice were infected
intranasallywith1107CFUofWTS.pneumoniaeorNanAmutant,andcytokinelevelsincell-freeBALﬂuidorlunghomogenatesweremeasuredbyELISA.
(A) TNF- in BAL ﬂuid at 6 h; (B) IL-6 in BAL ﬂuid at 20 h; (C) IL-1 in lung homogenates at 20 h; (D) IL-6 in lung homogenates at 20 h. (E) Recruitment of
inﬂammatorycellsfromthecirculationtoBALﬂuidwasdeterminedusingaBeckmanparticlecounter20hpostinfection.(F)Bacterialload(CFU)inBALﬂuids
of mice 20 h postinfection. Differences between the 2 groups were analyzed by Mann-Whitney test.
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oxygenspecies,releaseproteases,andsecreteIL-8(52,53).Onthe
other hand, galectin-1 inhibited nitric oxide synthesis and in-
creased the arginase activity of macrophages (54). The immuno-
modulatory effects of galectins may be integrated into the cumu-
lative effects on proinﬂammatory cytokine secretion observed
after NanA-mediated desialylation. However, due to the short-
durationexperimentsperformedonTHP-1cellsandneutrophils,
the endogenous concentration of galectins in our assay systems
should not be as high as those reported from studies in the previ-
ous literature, in which puriﬁed exogenous galectins were added
into immune cells. By knocking down the expression of Siglec-5,
wedemonstratedthatSiglec-cisligandinteractionsarethemselves
a critical control element in the activation status of immune cells.
AllS.pneumoniaeclinicalisolatesexpressthesurface-anchored
NanA(55,56),whichcancleaveterminalsialicacidresidues2-3
or 2-6 linked to galactose, mirroring the ligand preferences of
several CD33rSiglecs. NanA cleaves 2-3- and 2-6-linked sub-
strates with equal levels of efﬁciency and exhibits more than 10-
fold-greater overall sialidase activity than NanB, an enzyme that
exhibitsa5-foldpreferencefor2-3over2-6linkages(57).Prior
work has established that NanA plays multiple roles in S. pneu-
moniae pathogenesis, including modiﬁcation of the nasopharyn-
geal epithelial surface to reveal adherence receptors (58–61), bio-
ﬁlm formation (62), provision of free carbohydrates for bacterial
metabolism (31, 63, 64), desialylation of the cell surfaces of niche
competitorssuchasNeisseriameningitidisandHaemophilusinﬂu-
enzae(65),modiﬁcationofplateletstopromotetheirclearanceby
the hepatic Ashwell receptor (66), and blood-brain barrier endo-
thelialcellinvasion(32,67).Ourresultsaddstimulationofleuko-
cyte proinﬂammatory responses to the list of phenotypic changes
in the host associated with this multifactorial S. pneumoniae viru-
lence factor.
We also demonstrated that WT S. pneumoniae was more po-
tent than the NanA mutant in stimulating proinﬂammatory cy-
tokine production in BAL ﬂuid or lung homogenates following
murine intranasal challenge, ﬁndings associated with recovery of
fewer WT S. pneumoniae bacteria than NanA mutant bacteria
from BAL ﬂuid culture in the short-term-infection model. A re-
centreportdemonstratedthatWTS.pneumoniaeinducedgreater
inﬂammatory cytokine secretion and higher mortality than a
NanA NanB double mutant, even though similar CFU counts
of the two strains were recovered in the bloodstream following
intraperitoneal infection (68). Together, these data suggest that
augmented cytokine responses and neutrophil activation upon
Siglec-mediated “detection” of S. pneumoniae or of other
sialidase-expressingpathogenscouldboosttheinitiallocalizedin-
nateimmuneresponse;however,thesameprocessesduringsevere
infections could provoke widespread dysregulation of inhibitory
Siglecfunctionanduncontrolledsystemicinﬂammatoryreactions
that contribute to tissue injury, shock, or death. In this regard,
total sialidase activity measured by ﬂuorescent assay was signiﬁ-
cantlyhigherinbloodcollectedfromsepticpatientsthaninblood
from nonseptic patients or healthy controls (69).
Elevatedconcentrationsoffreesialicacidincerebrospinalﬂuid
(CSF)concentrationsweredetectedin17of35patientswithacute
S. pneumoniae meningitis, while patients with Haemophilus inﬂu-
enzae or Neisseria meningitidis meningitis had relatively normal
free CSF sialic acid levels (70). Previous work has shown that
NanA contributes to S. pneumoniae blood-brain barrier invasion
andmeningealinﬂammationinthemurinemeningitismodel(32,
67). Here we found that NanA-mediated proinﬂammatory cyto-
kine release from macrophages can increase the permeability of
hBMECs,whichmaybeafurthercontributingmechanismtobac-
terialandneutrophilinﬂuxintothecentralnervoussystem(CNS)
from the bloodstream.
Secondary S. pneumoniae pneumonia is a major complication
of inﬂuenza pneumonia and accounts for excess mortality during
inﬂuenza epidemics (71). In a mouse model of S. pneumoniae,
after inﬂuenza virus pulmonary infection, strikingly elevated lev-
elsofproinﬂammatorycytokines,includingTNF-,IL-6,andIL-
1, coupled with massive neutrophil inﬂux, were observed in the
lungs (72). A potential role for inﬂuenza virus neuraminidase in
this lethal synergism has been proposed to involve exposure of
binding receptors for S. pneumoniae on respiratory epithelium
(73).Ourpresentdatasuggestthat,inadditiontothismechanism,
the viral and bacterial neuraminidases could synergize during se-
vere infection to cause widespread cell surface desialylation and
trigger overexuberant pulmonary and systemic inﬂammatory re-
sponses.
In conclusion, we present the observation using WT and iso-
genic mutant S. pneumoniae bacteria that the NanA sialidase can
enhance the inﬂammatory response of immune cells. The un-
masking of inhibitory CD33rSiglecs to remove inhibition of
MAPK and NF-B signaling represents a potential mechanism
contributing to this phenomenon. Further analysis of sialic acid
andSiglecreceptorinteractionsduringhost-pathogenencounters
couldprovidenoveltargetsfortherapeuticinterventiontomodify
infectious disease outcome.
MATERIALS AND METHODS
Reagents. Puriﬁed sialidase from Arthrobacter ureafaciens and pneu-
moniae was purchased from EY Laboratories (San Mateo, CA) and QA-
Bio (Palm Desert, CA), respectively. Lipoteichoic acid was from Invivo-
Gen(SanDiego,CA),andVEGF165wasfromPeproTech(RockyHill,NJ).
Bacterial strains and growth conditions. S. pneumoniae serotype 2
strain D39 (NCTC 7466) and its isogenic NanA mutant were used for
these experiments. The NanA mutant was constructed by nonpolar al-
lelic replacement mutagenesis of the nanA gene as previously described
(46). Strains in which the NanA mutant was complemented with an
expression vector for the wild-type enzyme (pNanA) or a catalytically
inactive mutant enzyme (pNanAEnz) were previously validated by ﬂow
cytometry for surface expression of the protein (both plasmids) and ﬂu-
orescent assay. For restoration of sialidase activity (pNanA only) (32),
S. pneumoniae cultures were grown in Todd-Hewitt broth with 2% yeast
extract (THY media) THY with chloramphenicol (2 g/ml) was used to
propagate the complemented strains. Freshly cultured bacteria from fro-
zen aliquots were grown at 37°C in 5% CO2 and THY broth to the log
phase (optical density at 600 nm [OD600]  0.4) for all infection experi-
ments.
Cell culture and in vitro S. pneumoniae infection. THP-1 cells a
human acute monocytic leukemia cell line were cultured in RPMI 1640
medium supplemented with 10% fetal bovine serum (FBS). Human neu-
trophils were isolated from healthy donors by the use of the Polymor-
phPrep system (Axis-Shield, Fresenius, Waltham, MA) and were sus-
pendedinserum-freeRPMI1640mediumforexperiments.Cellsfromthe
well-characterized simian virus 40 (SV40) large T antigen-immortalized
human brain endothelial cell line (hBMEC), originally obtained from
Kwang Sik Kim (Johns Hopkins University, Baltimore, MD), was main-
tained in RPMI 1640 medium (Invitrogen) supplemented with 10% FBS,
10% NuSerum (BD Biosciences), and 1% nonessential amino acids.
THP-1 cells or neutrophils were resuspended in culture medium at the
cell density of 1  107/ml. WT S. pneumoniae and the NanA mutant
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bufferedsaline(PBS),andresuspendedinculturemediumtoanOD600
0.1 (~108 CFU/ml) and then further diluted to the desired inoculum.
Bacteria were added to 5  106 THP-1 cells or neutrophils in 2-ml sili-
conized microtubes at a multiplicity of infection (MOI) of 10, 3, or 1 as
speciﬁed. The mixture of leukocytes and bacteria was incubated at 37°C
with rotation, penicillin (5 g/ml) and gentamicin (100 g/ml) were
added30minafterinfectiontopreventbacterialovergrowth,andthecells
or supernatants were harvested at the indicated time points for analysis.
FACSanalysisofcellsurfacedesialylation.THP-1cellswereinfected
withWTS.pneumoniaeorNanAmutantatanMOIof10,3,or1for3h
as described above. After infection, cells were washed twice with PBS and
stained with ﬂuorescein isothiocyanate (FITC)-conjugated E. cristagalli
agglutinin lectin (Vector Laboratories, Burlingame, CA) for 30 min at
4°C. THP-1 cells were then washed twice and subjected to FACSCalibur
ﬂow cytometry (BD Biosciences) to analyze the exposed Gal1-
4GlcNAc1 units.
RNA interference. Human Siglec-5 lentiviral shRNA construct
(TRCN0000062525)waspurchasedfromOpenBiosystems.Thetargeting
viruses were produced by cotransfection of 293T cells with the shRNA
plasmid and packaging vectors (Open Biosystems) according to the ven-
dor’s instructions. Knockdown efﬁciency was determined by staining the
surface expression of Siglec-5 by the use of allophycocyanin (APC)-
conjugated anti-Siglec-5 monoclonal antibodies (MAbs) (BD Biosci-
ences).
Mouseintranasalinfectionandsamplecollection.Allanimalexper-
imentswereapprovedbytheCommitteeontheUseandCareofAnimals,
University of California, San Diego, and performed using accepted veter-
inary standards. Mice were lightly anesthetized by intraperitoneal injec-
tion of ketamine and xylazine, and 50 l of PBS containing 1  107 S.
pneumoniaeCFUwasthenadministeredintothenostrilsofthemice.The
inoculum dose was conﬁrmed by CFU counts on THY agar plates. In-
fectedanimalsweresacriﬁced6h(6miceineachgroup)or20h(7micein
eachgroup)postinfection.Bloodwascollectedviaterminalcardiacpunc-
ture. For bronchoalveolar lavage (BAL) ﬂuid collection, the trachea was
exposed and 0.8 ml of PBS (without calcium or anticoagulant) was in-
jected twice using an 18-gauge, 1 and 1/2-in.-long needle connected to a
1 ml syringe. A 25-l volume of BAL ﬂuid was serially diluted and plated
on THY plates to enumerate CFU. The rest of the BAL ﬂuid was centri-
fuged at 1,500 rpm for 10 min and the supernatant frozen at 80°C for
cytokine analysis. Cells were analyzed using a Z1 particle counter (Beck-
manCoulter)todeterminethetotalcellcountintheBALﬂuid.Theright
lung was excised and placed into sterile preweighed 2-ml screw-cap mi-
crotubes containing 1 ml of sterile PBS and 1-mm-diameter zirconia/
silica beads (BioSpec Products). After the tubes were weighed to deter-
minelungweight,lungtissuesweredisruptedbya1-minhomogenization
burst using a Mini-BeadBeater (BioSpec Products), followed by centrifu-
gation at 12,000 rpm to collect supernatants for cytokine analysis.
Cytokinedetection.TheconcentrationsofcytokinesinTHP-1super-
natants collected at various time points postinfection were quantiﬁed for
IL-6, IL-8, and TNF- using enzyme-linked immunosorbent assays
(ELISA)accordingtotheinstructionsofthemanufacturer(R&DSystems,
Minneapolis, MN). Mouse ELISA kits (TNF- and IL-6 from R&D and
IL-1 from BD Biosciences) were used to detect cytokines in BAL ﬂuids
and lung homogenates of infected animals.
Humanbrainmicrovascularendothelialcell(hBMEC)permeability
assay. hBMECs (2  104) were seeded on collagen-coated Transwell in-
serts(Costar)(poresize,3mm)for3to4daystoattainconﬂuence,which
was veriﬁed by direct visualization and resistance to Evans Blue dye leak-
age in control wells. At the beginning of the experiment, the medium in
theuppercompartmentwascarefullyreplacedwith150lofsupernatant
collected from uninfected, WT S. pneumoniae-infected, or NanA
mutant-infected THP-1 cells, while the lower compartment was replen-
ished with fresh medium. After8ho fincubation at 37°C with 5% CO2,
10lofhorseradishperoxidase(HRP)(50g/ml)wasaddedtotheupper
chamber for an additional 30 min. A 10-l volume of the medium from
the lower chamber was diluted in 190 l of PBS, followed by addition of
TMB substrate (BD Biosciences) for 20 min; the reaction was stopped by
the use of 2N H2SO4, and results were read at OD450.
Neutrophil extracellular trap (NET) visualization and quantiﬁca-
tion.Neutrophils(2.5105)wereseededon48-wellplates,infectedwith
WT S. pneumoniae or NanA mutant at an MOI  0.1, centrifuged at
1,600 rpm for 5 min, and incubated for 90 min at 37°C with 5% CO2.T o
visualize NETs, neutrophils were incubated with rabbit polyclonal anti-
bodies against myeloperoxidase (Dako), followed by staining with 4=,6=-
diamidino-2-phenylindole (DAPI) and Alexa Fluor 488-conjugated goat
anti-rabbit IgG (Invitrogen) as previously described (74). Images were
recorded using a Zeiss Axiovert microscope. The total amount of neutro-
philsandtheamountofneutrophilsreleasingNETsperﬁeldofviewwere
counted in 4 individual images per sample. The same investigator (Y.-C.
Chang) performed the experiment and the quantiﬁcation.
Western blot analysis. THP-1 cells were lysed in buffer (50 mM Tris
[pH 8], 150 mM NaCl, 1% NP-40) containing protease inhibitor cocktail
(Roche) and phosphatase inhibitor cocktail (Santa Cruz Biotechnology).
Cell lysates were then separated on a 10% sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) gel and transferred to a
polyvinylidene diﬂuoride (PVDF) membrane. The membrane was
probed with the anti-phospho-p44/42 MAPK (T202/Y204; Cell Signaling
Technology),anti-IB(CellSignalingTechnology),oranti-actin(Sigma)
Abs, followed by appropriate HRP-conjugated secondary Abs (Bio-Rad)
and ECL reagent (Thermo Scientiﬁc). Siglec-5 immunoprecipitation was
performed as previously described (75). Brieﬂy, 500 g of cell lysate was
immunoprecipitated with 1A5 anti-human Siglec-5 MAb (gift from P.
Crocker,UniversityofDundee,Dundee,Scotland,UnitedKingdom)and
protein G Sepharose beads (BD Biosciences). The Western blotting
method described above was used to probe samples with rabbit anti-
SHP-2 Abs (Santa Cruz Biotechnology).
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